Skip to content
Open access · CC-BY via OpenAlex

Age-related decline in LEPR+ hematopoietic stem cell function

Thao Le Phuong Trinh, James P. Ropa, Scott H. Cooper, Arafat Aljoufi, Anthony L. Sinn, Maegan L. Capitano, Hal E. Broxmeyer, Mark H. Kaplan

Leukemia · 2023 · ▲ 4 citations

Abstract

With the steady growth in the numbers of older individuals in the population worldwide, understanding how aging affects tissue-specific stem cells including the hematopoietic system will provide valuable insights for potential therapeutic interventions and disease prevention. Several studies have shown that hematopoietic stem cells (HSCs) exhibited age-associated phenotypes as early as middle age [ 1 ]. However, HSCs are a heterogenous group of cells, and the question remains whether HSC subsets are differentially affected by aging. Our previous work demonstrated in young mice that leptin receptor (LEPR) + HSCs, a highly engrafting subpopulation of HSCs expressing the truncated, non-functional isoform of LEPR under steady-state, exhibit transcriptomic programs enriched for type I interferon (IFN) and interferon-gamma (IFN-γ) associated pathways compared to LEPR - HSCs [ 2 ]. Beyond its role in embryonic HSC development, it is known that chronic IFN-γ signaling leads to HSC cycling and ultimately exhaustion [ 3 ]. Similarly, while short-term type I interferon stimulation is critical during an acute infection, long-term exposure as in chronic inflammation compromises HSC repopulating function [ 4 ]. Therefore, we hypothesized that LEPR + HSCs, due to their highly pro-inflammatory molecular programs at baseline, would be more highly susceptible to aged-associated dysfunctions. To test our hypothesis, we first assessed how aging altered phenotypically defined hematopoietic stem and progenitor cell proportions in the bone marrow (BM) of middle-aged (12–15-month-old) versus young (2–4-month-old) mice using fluorescence activated cell sorting (FACS) analysis. Consistent with our previous report, proportions of young LEPR-expressing long-term SLAM HSCs (Lin - Sca1 + c-Kit + Flt3 - CD150 + CD48 - ) (LSK Flt3 - CD150 + CD48 - , hereafter denoted as SLAM-HSC LT ) and short-term SLAM-HSCs (LSK Flt3 - CD150 - CD48 - or SLAM-HSC ST ) were significantly lower than LEPR - counterparts (Fig. 1A, B ) [ 2 , 5 ]. However, LEPR + SLAM-HSC LT exist at a higher proportion in aged mice as compared to young mice (Fig. 1A ). This same trend held true for a differently defined phenotypic LT-HSC (LSK CD34 - Flt3 - ), ST-HSC (LSK Flt3 - CD34 + ), multipotent progenitor (MPP, LSK Flt3 + CD34 + ), and subsets of MPPs including myeloid-biased MPP2 (LSK Flt3 - CD150 + CD48 + ), myeloid-biased MPP3 (LSK Flt3 - CD150 - CD48 + ), and lymphoid-biased MPP4 (LSK Flt3 + CD150 - CD48 + ) (Fig. S1A-F ) [ 6 , 7 ]. Interestingly, the difference in proportions between LEPR + and LEPR - of the MPP2 subset in young mice essentially disappeared as the mice aged. Together, these data suggested that the expansion of LEPR-expressing subsets of phenotypic HSCs and MPPs occurred at different kinetics, and the populations were significantly altered as early as middle age. Alternatively, this could also be due to loss or differentiation of LEPR - phenotypic HSCs and MPPs, or a combination of these factors. Fig. 1: Long-term LEPR + HSCs from middle-aged mice expanded in frequency with an accelerated decline in function as compared to young mice. A , B FACS analyses of freshly isolated total bone marrow (BM) cells from young and middle-aged C57BL/6 J ( n = 8–10). Percentages of LEPR + versus LEPR - cells within SLAM-HSC LT (LSK Flt3 - CD150 + CD48 - ) and SLAM-HSC ST (LSK Flt3 - CD150 - CD48 - ), respectively. C – F Equal numbers of freshly sorted LEPR + LSK vs. LEPR - LSK cells from young or middle-aged C57BL/6 J femur BM were used at different doses (shown here dose 1000) for limiting dilution assay (LDA). Donor chimerism in peripheral blood (PB) month 1, 2, 4 and BM month 4, respectively. G Poisson statistical analysis from the LDA. Solid lines represent the best-fit linear model for each data set; dotted lines represent 95% confidence intervals. Symbols represent the percentages of negative mice for each cell dose. This plot has been modified from the original for clarity purpose. H No. of CRUs per one million transplanted cells calculated from ( G ); line representing median; box representing 95% confidence interval. I , J For secondary transplant, two millions of total BM cells pooled from primary hosts were intravenously injected into lethally irradiated secondary hosts. Donor chimerism in PB and BM at month 4, respectively. K , L Equal numbers of freshly sorted LEPR + SLAM-HSCs (LSK CD150 + CD48 - ) vs. LEPR - SLAM HSCs from young or middle-aged C57BL/6 J femur BM were used at different doses for an LDA. K Poisson statistical analysis from the LDA. Solid lines represent the best-fit linear model for each data set; dotted lines represent 95% confidence intervals. Symbols represent the percentages of negative mice for each cell dose. This plot has been modified from the original for clarify purpose. L No. of CRUs per one million transplanted cells calculated from ( K ); line representing median; box representing 95% confidence interval. All data are mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 using Ordinary Two-way ANOVA followed with post hoc Tukey’s multiple comparison test. N = 2 independently repeated experiments. Full size image HSCs from aged mice are present at higher numbers (Fig. S1G, H ), but exhibit a significant decline in repopulating potential [ 8 ]. To determine whether middle-aged LEPR + LSKs contained fewer competitive repopulating units (CRUs, a functional measure of murine HSCs) compared to the young cells, we performed limiting dilution engraftment assay (LDA) using increasing doses of equal numbers of LEPR + or LEPR - LSK cells from young or middle-aged mice. Consistent with previous studies, young LEPR + LSK cells possessed superior repopulating capacity compared to LEPR - LSK cells demonstrated by significantly higher donor chimerism in peripheral blood (PB) at month 1, 2, 4 (Fig. 1C–E ) and BM at month 4 (Fig. 1F ) as well as absolute number of CRUs (Fig. 1G, H , S2D ) [ 2 ]. Compared to you

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1038/s41375-023-01815-1
Canonical
link ↗
Fetched
2026-10-06 MST

Cite this

APA
Trinh, T.L.P., Ropa, J.P., Cooper, S.H., Aljoufi, A., Sinn, A.L., Capitano, M.L., Broxmeyer, H.E., &amp; Kaplan, M.H. (2023). Age-related decline in LEPR+ hematopoietic stem cell function. <em>Leukemia</em>. https://doi.org/10.1038/s41375-023-01815-1
Vancouver
Trinh TLP, Ropa JP, Cooper SH, Aljoufi A, Sinn AL, Capitano ML, et al. Age-related decline in LEPR+ hematopoietic stem cell function. Leukemia. 2023. doi:10.1038/s41375-023-01815-1.
BibTeX
@article{thao2023Agerel, title = {Age-related decline in LEPR+ hematopoietic stem cell function}, author = {Thao Le Phuong Trinh and James P. Ropa and Scott H. Cooper and Arafat Aljoufi and Anthony L. Sinn and Maegan L. Capitano and Hal E. Broxmeyer and Mark H. Kaplan}, journal = {Leukemia}, year = {2023}, doi = {10.1038/s41375-023-01815-1}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings